Anti-IgE vaccines
US6887472B2 · kind B2 · utility
8Cited by
2References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 24, 2001 |
| Grant date | May 3, 2005 |
| Priority date | — |
| Expiry date | Aug 15, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for the use of antigenic peptides derived from the Fc portion of the epsilon heavy chain of an IgE molecule as vaccines for the treatment and prevention of IgE-mediated allergic disorders. In particular, the invention provides compositions, methods for the treatment and prevention of IgE-mediated allergic disorders comprising an immunogenic amount of one or more antigenic peptides derived from the CH3 domain or junction of Ch-3/CH4 domain of an IgE molecule and methods for the evaluation of IgE mediated allergies in dogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.